Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer

Jiang Yu(Nanfang Hospital), Chang‐Ming Huang(Fujian Medical University), Yihong Sun(Sun Yat-sen University), Xiangqian Su(Peking University), Hui Cao(Shanghai Jiao Tong University), Jian‐Kun Hu(Sichuan University), Kuan Wang(Harbin Medical University), Jian Suo(Jilin University), Kaixiong Tao(Union Hospital), Xianli He(Air Force Medical University), Hongbo Wei(Sun Yat-sen University), Mingang Ying(Fujian Provincial Cancer Hospital), Weiguo Hu(Shanghai Jiao Tong University), Xiaohui Du(Chinese PLA General Hospital), Yanfeng Hu(Nanfang Hospital), Hao Liu(Nanfang Hospital), Chao‐Hui Zheng(Fujian Medical University), Ping Li(Fujian Medical University), Jian‐Wei Xie(Fujian Medical University), Fenglin Liu(Sun Yat-sen University), Ziyu Li(Peking University), Gang Zhao(Shanghai Jiao Tong University), Kun Yang(Sichuan University), Chunxiao Liu(Harbin Medical University), Haojie Li(Sun Yat-sen University), Pingyan Chen(Southern Medical University), Jiafu Ji(Peking University), Guoxin Li(Nanfang Hospital), for the Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group
JAMA
May 28, 2019
Cited by 707Open Access
Full Text

Abstract

Importance: Laparoscopic distal gastrectomy is accepted as a more effective approach to conventional open distal gastrectomy for early-stage gastric cancer. However, efficacy for locally advanced gastric cancer remains uncertain. Objective: To compare 3-year disease-free survival for patients with locally advanced gastric cancer after laparoscopic distal gastrectomy or open distal gastrectomy. Design, Setting, and Patients: The study was a noninferiority, open-label, randomized clinical trial at 14 centers in China. A total of 1056 eligible patients with clinical stage T2, T3, or T4a gastric cancer without bulky nodes or distant metastases were enrolled from September 2012 to December 2014. Final follow-up was on December 31, 2017. Interventions: Participants were randomized in a 1:1 ratio after stratification by site, age, cancer stage, and histology to undergo either laparoscopic distal gastrectomy (n = 528) or open distal gastrectomy (n = 528) with D2 lymphadenectomy. Main Outcomes and Measures: The primary end point was 3-year disease-free survival with a noninferiority margin of -10% to compare laparoscopic distal gastrectomy with open distal gastrectomy. Secondary end points of 3-year overall survival and recurrence patterns were tested for superiority. Results: Among 1056 patients, 1039 (98.4%; mean age, 56.2 years; 313 [30.1%] women) had surgery (laparoscopic distal gastrectomy [n=519] vs open distal gastrectomy [n=520]), and 999 (94.6%) completed the study. Three-year disease-free survival rate was 76.5% in the laparoscopic distal gastrectomy group and 77.8% in the open distal gastrectomy group, absolute difference of -1.3% and a 1-sided 97.5% CI of -6.5% to ∞, not crossing the prespecified noninferiority margin. Three-year overall survival rate (laparoscopic distal gastrectomy vs open distal gastrectomy: 83.1% vs 85.2%; adjusted hazard ratio, 1.19; 95% CI, 0.87 to 1.64; P = .28) and cumulative incidence of recurrence over the 3-year period (laparoscopic distal gastrectomy vs open distal gastrectomy: 18.8% vs 16.5%; subhazard ratio, 1.15; 95% CI, 0.86 to 1.54; P = .35) did not significantly differ between laparoscopic distal gastrectomy and open distal gastrectomy groups. Conclusions and Relevance: Among patients with a preoperative clinical stage indicating locally advanced gastric cancer, laparoscopic distal gastrectomy, compared with open distal gastrectomy, did not result in inferior disease-free survival at 3 years. Trial Registration: ClinicalTrials.gov Identifier: NCT01609309.


Related Papers

No related papers found

Powered by citation graph analysis